Valveclip repair study for leaking mitral valve in older adults
Part of Heart & circulation clinical trials.
This trial tests Valveclip, a catheter-based way to repair a mitral valve that is leaking badly. It may help people who are high-risk for open surgery by aiming to reduce the leak with a less invasive approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe mitral valve leaking (moderate or worse, often described as 3+ or higher)
- Your age is 70 or older, or you are 60–70 and considered high-risk for regular open surgery
- Your heart pump strength is not too low (left ventricle ejection fraction at least 30%)
- You can have the procedure through a catheter route (doctors say your valve/heart shape fits this plan)
- Your valve leak comes from the A2/P2 parts of the mitral valve, and the valve measurements meet specific limits
- You agree to the trial, sign consent, and return for required tests and follow-up
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clip-based procedure (TEER) to fix a severe leak in the mitral valve for people who have symptoms or heart changes but are at low to medium risk for surgery. The goal is to see if this less invasive option works well and is safe.
This trial studies whether a device called GeminiOne can safely and effectively repair a leaky mitral valve using a catheter-based “clip” technique. It may help patients who have moderate-to-severe or severe valve leakage but are considered too high-risk for open surgery.
This study tests a new clip procedure (CardioClip) to repair a leaky mitral valve in people with heart failure. It aims to see if the clip can improve symptoms and heart function.
This study looks at how long a new mitral valve treatment/device can stay working in people with moderate-to-severe or severe mitral valve leak. It may help avoid or delay surgery for people considered higher risk for mitral valve repair.
This trial tests a new device called the Capstan system to fix a leaky mitral valve (mitral regurgitation) without open-heart surgery. It may help people whose valve leak is moderate to severe and still have symptoms despite medicines.
This trial compares two treatment approaches for people with heart failure and a leaky mitral valve (mitral regurgitation). It aims to find which strategy leads to better outcomes. You may be eligible if your heart function is reduced and you have symptoms despite standard treatments.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.